4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
The Current Biomarker Landscape in Immuno-Oncology
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs
Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development